<!DOCTYPE HTML>
<html>
  <head>
    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    <meta http-equiv="Content-type" content="text/html; charset=utf-8">
	<title>Methadone</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Methadone</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand names: Dolophine, Methadose</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Specialty consultation advised </li>
						<li>Titrate carefully, consider methadone's delayed cumulative effects </li>
						<li>Individualize dosing regimens (AVOID the same fixed dose for all patients)</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>Give orally in a single daily dose </li>
						<li>FDA approved for detoxification treatment and maintenance treatment of Opioid dependence in conjunction with appropriate social and medical services</li>
					</ul>
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li>Contraindications include any situation where Opioids are contraindicated, such as patients with respiratory depression (in the absence of resuscitative equipment or in unmonitored situations) and patients with acute bronchial asthma or hypercarbia and known or suspected paralytic ileus</li> 
						<li>May prolong QTc intervals on ECG; Risk of cardiac arrhythmias </li>
						<li>Discontinue or taper the methadone dose and consider an alternative therapy if the QTc &gt; 500ms </li>
						<li>Plasma half-life may be longer than the analgesic duration </li>
						<li>Delayed analgesia or toxicity may occur because of drug accumulation after repeated doses, e.g., on days 2 to 5; If patient has excessive sedation during this timeframe, consider temporarily holding dose(s), lowering the dose, and/or slowing the titration rate</li> 
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
							<li>Positive evidence of risk; However potential benefits may outweigh potential risks</li>	
					</ul>
<hr>
					<h3>Safety Margin for OATs</h3>	
					<ul>
						<li>Serious overdose and death may occur if benzodiazepines, sedatives, tranquilizers, antidepressants, alcohol or other CNS depressants are taken in addition </li>
						<li>Avoid concurrent use of methadone with nilotinib, tetrabenazine, ziprasidone, alcohol, st. johns wort, valerian, kava kava and grapefruit juice</li> 
						<li>Methadone contraindicated with selegiline</li> 
						<li>Avoid concurrent use of buprenorphine with alcohol, st. johns wort, valerian and kava kava</li>
						
					</ul>
<hr>
					<h3>Efficacy for OATs</h3>	
					<ul>
						<li>Methadone is FDA approved for the management of moderate to severe pain</li>		
					</ul>
						



    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
